The lawsuit also argues that Zepbound has been proven to be more effective for weight loss, and, on its formulary page for the switch, CVS acknowledges that studies with that implication exist while saying "real-world evidence suggests the two are comparable." "Because of their different methods of action, different clinical outcomes, and different side effects for individual patients, Zepbound and Wegovy are not clinically interchangeable," the plaintiffs said in their complaint
10.3390/ijms21218364 35 FrediansyahA.StraetenerJ.Brtz-OesterheltH.GrossH
These patients often experience multiple comorbidities, such as diabetes and cardiovascular disease, where GLP-1 therapies offer additional health benefits beyond weight loss
Melanocytic activation consisting of a normal number of melanocytes increasing their production of melanin (sometimes due to external trauma)
Functional Medicine doctors are fully trained MDs who complete medical school, residency, and licensing just like conventional physicians